Table 1

Baseline demographic data in HIV-infected children with NP specimens

Patients N = 203


Female

96 (47.3%)


Median age (IQ range)

1.8 (0.7 – 4) years


CDC Clinical Class

N

2 (0.9%)

A

17 (8.4%)

B

138 (68%)

C

46 (22.7%)


CDC Immunological

1

44 (22%)

2

85 (42.5%)

3

71 (35.5%)


CD4 percentage

19 (14 – 26)


Hospitalization

None in past

52 (25.6%)

1

54 (26.6%)

2

53 (26.11%)

3

28 (13.79%)

4

11 (5.42%)

5

5 (2.46%)

Recruited to study during or immediately after current hospitalization

91 (44.8%)

No hospitalization

38 (18.7%)


TMP-SMX status


No previous experience

47 (23.3%)

On drug at baseline

141 (69.8)

History of exposure

15 (7.4%)


Median weight for age Z-score (IQ range)

-1.6 (-3 – -0.4)

Antiretroviral therapy at baseline

19 (9.4%)

Time on therapy

0.5 (0.2 – 1.1) years


Died within 12 months of enrolment

35 (17.2%)


Cotton et al. BMC Infectious Diseases 2008 8:40   doi:10.1186/1471-2334-8-40

Open Data